Michael C. Feld
Executive Vice President, Chief Revenue Officer And President, Life Sciences Segment
Becton, Dickinson and Company · BDX
$4.1M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed December 18, 2025. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $775K
- Stock Awards
- $1.6M
- Option Awards
- $544K
- Incentives
- $534K
- Other
- $602K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $775,000 | $1,641,596 | $4,096,356 |
Current Position
- Title
- Executive Vice President, Chief Revenue Officer And President, Life Sciences Segment
- Ticker
- BDX · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed December 18, 2025), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
Accession 0001628280-25-057846.
Other BD Executives
Thomas E. Polen
Chairman, Chief Executive Officer And President
BD · BDX
$17.1M
FY 2025 · DEF 14A
Christopher J. Del Orefice
Executive Vice President And Chief Financial Officer
BD · BDX
$5.9M
FY 2025 · DEF 14A
Richard E. Byrd
Executive Vice President And President, Interventional Segment
BD · BDX
$3.4M
FY 2025 · DEF 14A
Michael D. Garrison
Executive Vice President And President, Medical Essentials And Bio Pharma Systems Segments
BD · BDX
$3.6M
FY 2025 · DEF 14A